Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2021-04-01
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Caffeine on Cerebral Blood Flow
NCT05866848
Action of Caffeinated and Decaffeinated Espresso on Autonomic Function
NCT00576030
Arrhythmic Effects of Hight Dose Caffeine
NCT02045992
Genetic Determinants of Cardiovascular Response to Coffee Drinking
NCT01330680
Cognitive and Cerebral Blood Flow Effects of 2-week Caffeine Abstinence or Maintenance
NCT01376882
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coffee
Oral consumption of 3 cups of coffee containing 240 mg caffeine
caffeine
oral consumption
Energy drink
Oral consumption of 750 mL of a commercial energy drink containing 240 mg caffeine
caffeine
oral consumption
Placebo
Oral consumption of 750 mL water
caffeine
oral consumption
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
caffeine
oral consumption
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years
Exclusion Criteria
* other diseases which may influence the autonomic nervous system
* medication which may influence the autonomic nervous system
* prior caffeine consumption (\<24 hours)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LMU Klinikum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PD Dr. Stefan Brunner
Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Munich (LMU Klinikum)
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Schuttler D, Rudi WS, Bauer A, Hamm W, Brunner S. Impact of energy drink versus coffee consumption on periodic repolarization dynamics: an interventional study. Eur J Nutr. 2022 Aug;61(5):2847-2851. doi: 10.1007/s00394-022-02853-8. Epub 2022 Mar 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CaffeineLMU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.